SANTINI, VALERIA
SANTINI, VALERIA
Medicina Sperimentale e Clinica
5-Azacytidine for the Treatment of Acute Myeloid Leukemia: A Retrospective, Multicenter Study of 55 Patients.
2008 Luca Maurillo; Alessandra Spagnoli; Mariella Genuardi; Monia Lunghi; Nicola Di Renzo; Alfonso Maria D’Arco; Giuseppe Mele; Alessandro Levis; Antonella Gozzini; Mario Petrini; Manuela Mianulli; Grazia Sanpaolo; Alberto Santagostino; Giuseppe Pietrantuono; Fiorella D’Auria; Dario Ferrero; Gianluca Gaidano; Felicetto Ferrara; Adriano Venditti; Giuseppe Leone; Valeria Santini; and Pellegrino Musto
5-Azacytidine in 82 Low/Intermediate-1 IPSS Risk Myelodysplastic Syndromes: Results from the Italian Patient Named Program
2008 Pellegrino Musto; Luca Maurillo; Alessandra Spagnoli; Antonella Gozzini; Flavia Rivellini; Caterina Tatarelli; Monia Lunghi; Carla Fili; Enrico Orciuolo; Lucia Ciuffreda; Ernesto Vigna; Paola Della Cioppa; Anna Candoni; Dario Ferrero; Salvatore Palmieri; Giuseppe Palumbo; Nicola Di Renzo; Esther Oliva; Grazia Sanpaolo; Domenico Pastore; Anna Tonso; Alberto Santagostino; Stefano Rocco; Oreste Villani; Fiorella D’Auria; Alfonso Maria D’Arco; Gianluca Gaidano; Sara Galimberti; Domenico Russo; Adriano Venditti; Maria Antonietta Aloe-Spiriti; Giuseppe Leone; and Valeria Santini
5-Azacytidine, Valproic Acid and ALL-Trans Retinoic Acid in INT-2/High Risk Myelodysplastic Syndromes: Results of the GIMEMA MDS0205 Multicenter TrialBlood (ASH Annual Meeting Abstracts), Nov 2008; 112: 3648.
2008 Maria Teresa Voso; Valeria Santini; Carlo Finelli; Lorenza Borin; Emanuele Angelucci; Giuseppe Fioritoni; Benedetta Neri; Agostino Cortellezi; Oreste Villani; Francesco Buccisano; Giovanni Martinelli; Maria Concetta Petti; Gina Zini; Alfonso Piciocchi; Paola Fazi; Giuliana Alimena; Marco Gobbi; Vincenzo Liso; and Giuseppe Leone
[GM-CSF: its clinical administration; the treatment of aplasia]
1989 P. Rossi Ferrini; A. Grossi; V. Santini; A. M. Vannucchi
A comparison of two assays for the in vitro chemosensitivity testing of human acute non-lymphoblastic leukemia cells.
1989 Dal Pozzo O;Bernabei PA;Santini V;Saccardi R;Santini S;Rossi Ferrini P
A G polymorphism in the CRBN gene acts as a biomarker of response to treatment with lenalidomide in low/int-1 risk MDS without del(5q).
2013 Sardnal V; Rouquette A; Kaltenbach S; Bally C; Chesnais V; Leschi C; Ades L; Santini V; Park S; Toma A; Fenaux P; Dreyfus F; Fontenay M; Kosmider O.
A multivariate analysis of the relationship between response and survival among patients with higher-risk myelodysplastic syndromes treated within azacitidine or conventional care regimens in the randomized AZA-001 trial.
2013 SD Gore SD, ; Fenaux, P.; Santini, Valeria; Bennett, Jm; Silverman, Lr; Seymour, Jf; Hellström Lindberg, E.; Swern, As; Beach, Cl; List, Af
A Nationwide Study of GATA2 Deficiency in Italy Reveals Novel Symptoms and Genotype–phenotype Association
2023 Roncareggi, Samuele; Girardi, Katia; Fioredda, Francesca; Pedace, Lucia; Arcuri, Luca; Badolato, Raffaele; Bonanomi, Sonia; Borlenghi, Erika; Cirillo, Emilia; Coliva, Tiziana; Consonni, Filippo; Conti, Francesca; Farruggia, Piero; Gambineri, Eleonora; Guerra, Fabiola; Locatelli, Franco; Mancuso, Gaia; Marzollo, Antonio; Masetti, Riccardo; Micalizzi, Concetta; Onofrillo, Daniela; Piccini, Matteo; Pignata, Claudio; Raddi, Marco Gabriele; Santini, Valeria; Vendemini, Francesca; Biondi, Andrea; Saettini, Francesco
A phase 3 randomized, placebo-controlled study assessing the efficacy and safety of epoetin-α in anemic patients with low-risk MDS
2018 Fenaux P.; Santini V.; Spiriti M.A.A.; Giagounidis A.; Schlag R.; Radinoff A.; Gercheva-Kyuchukova L.; Anagnostopoulos A.; Oliva E.N.; Symeonidis A.; Berger M.H.; Gotze K.S.; Potamianou A.; Haralampiev H.; Wapenaar R.; Milionis I.; Platzbecker U.
A selective activity of DNMTi decitabine on AML1ETO positive cells?
2007 V. SANTINI
A systematic analysis of bone marrow cells by flow cytometry defines a specific phenotypic profile beyond GPI deficiency in paroxysmal nocturnal hemoglobinuria.
2013 Mannelli F; Bencini S; Peruzzi B; Cutini I; Sanna A; Benelli M; Magi A; Gianfaldoni G; Rotunno G; Carrai V; Gelli AM; Valle V; Santini V; Notaro R; Luzzatto L; Bosi A.
A variant erythroferrone disrupts iron homeostasis in SF3B1-mutated myelodysplastic syndrome
2019 Bondu S.; Alary A.-S.; Lefevre C.; Houy A.; Jung G.; Lefebvre T.; Rombaut D.; Boussaid I.; Bousta A.; Guillonneau F.; Perrier P.; Alsafadi S.; Wassef M.; Margueron R.; Rousseau A.; Droin N.; Cagnard N.; Kaltenbach S.; Winter S.; Kubasch A.-S.; Bouscary D.; Santini V.; Toma A.; Hunault M.; Stamatoullas A.; Gyan E.; Cluzeau T.; Platzbecker U.; Ades L.; Puy H.; Stern M.-H.; Karim Z.; Mayeux P.; Nemeth E.; Park S.; Ganz T.; Kautz L.; Kosmider O.; Fontenay M.
Absence of aberrant myeloid progenitors by flow cytometry is associated with favorable response to azacitidine in higher risk myelodysplastic syndromes
2014 Alhan, Canan; Westers, Theresia M.; van der Helm, Lieke H.; Eeltink, Corien; Huls, Gerwin; Witte, Birgit I.; Buchi, Francesca; Santini, Valeria; Ossenkoppele, Gert J.; van de Loosdrecht, Arjan A.
ACETYLATION INDUCED BY BUTYRATES IN PATIENTS WITH ACUTE MYELOID LEUKEMIA CAN LEAD TO DIFFENTIATION
2002 A. Gozzini; E. Rovida; A Pratesi; P. Dello Sbarba; P Rossi Ferrini; V. Santini
Acetylome and phosphoproteome modifications in imatinib resistant chronic myeloid leukaemia cells treated with valproic acid.
2011 Buchi, F; Pastorelli, R; Ferrari, G; Spinelli, E; Gozzini, A; Sassolini, F; Bosi, Alberto; Tombaccini, D; Santini, Valeria
Acetylome and phosphoproteome modifications in imatinib resistant chronic myeloid leukaemia cells treated with valproic acid.
2011 Buchi F; Pastorelli R; Ferrari G; Spinelli E; Gozzini A; Sassolini F; Bosi A; Tombaccini D; Santini V
Achievement of red blood cell transfusion independence in red blood cell transfusion-dependent patients with lower-risk non-del(5q) myelodysplastic syndromes correlates with serum erythropoietin levels
2020 Santini V.; Almeida A.; Giagounidis A.; Skikne B.; Beach C.L.; Weaver J.; Tu N.; Fenaux P.
Activity of vinorelbine on B-chronic lymphocytic leukemia cells in vitro.
1999 Bernabei PA;Landini I;Bartolozzi B;Banchelli I;Degli Innocenti o Nocentini A;Santini V;Ematologia UO
Acute myeloid leukemias with chromosomal abnormalities involving the 21q22 region identified by their in vitro responsiveness to interleukin-5.
1991 TOUW I; DONATH J; POUWELS K; VAN BUITENEN C; SCHIPPER P; V. SANTINI; HAGEMEIJER A; LOWENBERG B; DELWEL R.
Advances in myelodysplastic syndrome.
2021 Valeria Santini
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| 5-Azacytidine for the Treatment of Acute Myeloid Leukemia: A Retrospective, Multicenter Study of 55 Patients. | 2008 | Luca Maurillo; Alessandra Spagnoli; Mariella Genuardi; Monia Lunghi; Nicola Di Renzo; Alfonso Maria D’Arco; Giuseppe Mele; Alessandro Levis; Antonella Gozzini; Mario Petrini; Manuela Mianulli; Grazia Sanpaolo; Alberto Santagostino; Giuseppe Pietrantuono; Fiorella D’Auria; Dario Ferrero; Gianluca Gaidano; Felicetto Ferrara; Adriano Venditti; Giuseppe Leone; Valeria Santini; and Pellegrino Musto | |
| 5-Azacytidine in 82 Low/Intermediate-1 IPSS Risk Myelodysplastic Syndromes: Results from the Italian Patient Named Program | 2008 | Pellegrino Musto; Luca Maurillo; Alessandra Spagnoli; Antonella Gozzini; Flavia Rivellini; Caterina Tatarelli; Monia Lunghi; Carla Fili; Enrico Orciuolo; Lucia Ciuffreda; Ernesto Vigna; Paola Della Cioppa; Anna Candoni; Dario Ferrero; Salvatore Palmieri; Giuseppe Palumbo; Nicola Di Renzo; Esther Oliva; Grazia Sanpaolo; Domenico Pastore; Anna Tonso; Alberto Santagostino; Stefano Rocco; Oreste Villani; Fiorella D’Auria; Alfonso Maria D’Arco; Gianluca Gaidano; Sara Galimberti; Domenico Russo; Adriano Venditti; Maria Antonietta Aloe-Spiriti; Giuseppe Leone; and Valeria Santini | |
| 5-Azacytidine, Valproic Acid and ALL-Trans Retinoic Acid in INT-2/High Risk Myelodysplastic Syndromes: Results of the GIMEMA MDS0205 Multicenter TrialBlood (ASH Annual Meeting Abstracts), Nov 2008; 112: 3648. | 2008 | Maria Teresa Voso; Valeria Santini; Carlo Finelli; Lorenza Borin; Emanuele Angelucci; Giuseppe Fioritoni; Benedetta Neri; Agostino Cortellezi; Oreste Villani; Francesco Buccisano; Giovanni Martinelli; Maria Concetta Petti; Gina Zini; Alfonso Piciocchi; Paola Fazi; Giuliana Alimena; Marco Gobbi; Vincenzo Liso; and Giuseppe Leone | |
| [GM-CSF: its clinical administration; the treatment of aplasia] | 1989 | P. Rossi Ferrini; A. Grossi; V. Santini; A. M. Vannucchi | |
| A comparison of two assays for the in vitro chemosensitivity testing of human acute non-lymphoblastic leukemia cells. | 1989 | Dal Pozzo O;Bernabei PA;Santini V;Saccardi R;Santini S;Rossi Ferrini P | |
| A G polymorphism in the CRBN gene acts as a biomarker of response to treatment with lenalidomide in low/int-1 risk MDS without del(5q). | 2013 | Sardnal V; Rouquette A; Kaltenbach S; Bally C; Chesnais V; Leschi C; Ades L; Santini V; Park S; Toma A; Fenaux P; Dreyfus F; Fontenay M; Kosmider O. | |
| A multivariate analysis of the relationship between response and survival among patients with higher-risk myelodysplastic syndromes treated within azacitidine or conventional care regimens in the randomized AZA-001 trial. | 2013 | SD Gore SD, ; Fenaux, P.; Santini, Valeria; Bennett, Jm; Silverman, Lr; Seymour, Jf; Hellström Lindberg, E.; Swern, As; Beach, Cl; List, Af | |
| A Nationwide Study of GATA2 Deficiency in Italy Reveals Novel Symptoms and Genotype–phenotype Association | 2023 | Roncareggi, Samuele; Girardi, Katia; Fioredda, Francesca; Pedace, Lucia; Arcuri, Luca; Badolato, Raffaele; Bonanomi, Sonia; Borlenghi, Erika; Cirillo, Emilia; Coliva, Tiziana; Consonni, Filippo; Conti, Francesca; Farruggia, Piero; Gambineri, Eleonora; Guerra, Fabiola; Locatelli, Franco; Mancuso, Gaia; Marzollo, Antonio; Masetti, Riccardo; Micalizzi, Concetta; Onofrillo, Daniela; Piccini, Matteo; Pignata, Claudio; Raddi, Marco Gabriele; Santini, Valeria; Vendemini, Francesca; Biondi, Andrea; Saettini, Francesco | |
| A phase 3 randomized, placebo-controlled study assessing the efficacy and safety of epoetin-α in anemic patients with low-risk MDS | 2018 | Fenaux P.; Santini V.; Spiriti M.A.A.; Giagounidis A.; Schlag R.; Radinoff A.; Gercheva-Kyuchukova L.; Anagnostopoulos A.; Oliva E.N.; Symeonidis A.; Berger M.H.; Gotze K.S.; Potamianou A.; Haralampiev H.; Wapenaar R.; Milionis I.; Platzbecker U. | |
| A selective activity of DNMTi decitabine on AML1ETO positive cells? | 2007 | V. SANTINI | |
| A systematic analysis of bone marrow cells by flow cytometry defines a specific phenotypic profile beyond GPI deficiency in paroxysmal nocturnal hemoglobinuria. | 2013 | Mannelli F; Bencini S; Peruzzi B; Cutini I; Sanna A; Benelli M; Magi A; Gianfaldoni G; Rotunno G; Carrai V; Gelli AM; Valle V; Santini V; Notaro R; Luzzatto L; Bosi A. | |
| A variant erythroferrone disrupts iron homeostasis in SF3B1-mutated myelodysplastic syndrome | 2019 | Bondu S.; Alary A.-S.; Lefevre C.; Houy A.; Jung G.; Lefebvre T.; Rombaut D.; Boussaid I.; Bousta A.; Guillonneau F.; Perrier P.; Alsafadi S.; Wassef M.; Margueron R.; Rousseau A.; Droin N.; Cagnard N.; Kaltenbach S.; Winter S.; Kubasch A.-S.; Bouscary D.; Santini V.; Toma A.; Hunault M.; Stamatoullas A.; Gyan E.; Cluzeau T.; Platzbecker U.; Ades L.; Puy H.; Stern M.-H.; Karim Z.; Mayeux P.; Nemeth E.; Park S.; Ganz T.; Kautz L.; Kosmider O.; Fontenay M. | |
| Absence of aberrant myeloid progenitors by flow cytometry is associated with favorable response to azacitidine in higher risk myelodysplastic syndromes | 2014 | Alhan, Canan; Westers, Theresia M.; van der Helm, Lieke H.; Eeltink, Corien; Huls, Gerwin; Witte, Birgit I.; Buchi, Francesca; Santini, Valeria; Ossenkoppele, Gert J.; van de Loosdrecht, Arjan A. | |
| ACETYLATION INDUCED BY BUTYRATES IN PATIENTS WITH ACUTE MYELOID LEUKEMIA CAN LEAD TO DIFFENTIATION | 2002 | A. Gozzini; E. Rovida; A Pratesi; P. Dello Sbarba; P Rossi Ferrini; V. Santini | |
| Acetylome and phosphoproteome modifications in imatinib resistant chronic myeloid leukaemia cells treated with valproic acid. | 2011 | Buchi, F; Pastorelli, R; Ferrari, G; Spinelli, E; Gozzini, A; Sassolini, F; Bosi, Alberto; Tombaccini, D; Santini, Valeria | |
| Acetylome and phosphoproteome modifications in imatinib resistant chronic myeloid leukaemia cells treated with valproic acid. | 2011 | Buchi F; Pastorelli R; Ferrari G; Spinelli E; Gozzini A; Sassolini F; Bosi A; Tombaccini D; Santini V | |
| Achievement of red blood cell transfusion independence in red blood cell transfusion-dependent patients with lower-risk non-del(5q) myelodysplastic syndromes correlates with serum erythropoietin levels | 2020 | Santini V.; Almeida A.; Giagounidis A.; Skikne B.; Beach C.L.; Weaver J.; Tu N.; Fenaux P. | |
| Activity of vinorelbine on B-chronic lymphocytic leukemia cells in vitro. | 1999 | Bernabei PA;Landini I;Bartolozzi B;Banchelli I;Degli Innocenti o Nocentini A;Santini V;Ematologia UO | |
| Acute myeloid leukemias with chromosomal abnormalities involving the 21q22 region identified by their in vitro responsiveness to interleukin-5. | 1991 | TOUW I; DONATH J; POUWELS K; VAN BUITENEN C; SCHIPPER P; V. SANTINI; HAGEMEIJER A; LOWENBERG B; DELWEL R. | |
| Advances in myelodysplastic syndrome. | 2021 | Valeria Santini |